Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products

Plentz, Annelie and Hahn, Joachim and Knoell, Antje and Holler, Ernst and Jilg, Wolfgang and Modrow, Susanne (2005) Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products. TRANSFUSION, 45 (11). pp. 1811-1815. ISSN 0041-1132, 1537-2995

Full text not available from this repository. (Request a copy)

Abstract

BACKGROUND: Patients with hematologic malignancies often require blood products, and parvovirus B19 is known to be transmitted by this route. Primary infection with parvovirus B19 shows a wide variety of disease manifestation. In immunocompromised patients, symptoms are severe and viral clearance is delayed or missing. STUDY DESIGN AND METHODS: A total of 2123 blood products given to all patients of a hematologic ward over a period of 6 months were retrospectively examined for the presence of parvovirus B19 DNA by an in-house real-time polymerase chain reaction (PCR; TaqMan). Patients who had received B19 DNA-positive blood products were further investigated serologically and by PCR for the presence of parvovirus B19 antibodies and DNA. RESULTS: Twenty-one (1%) of 2123 blood products tested positive for the presence of B19 DNA (2% of pooled products, 0.7% of single-donor products, and 17.6% of allogeneic peripheral blood progenitor cells), the median viral load was 700 genome equivalents per mL. During the study period, 114 patients were treated on the ward, and 14 (12%) of them received B19 DNA-positive blood components. None of them developed symptoms of an acute B19 infection, although one had a short low-level viremia. CONCLUSIONS: Although B19 DNA was detected in 1 percent of blood products given to hematologic patients, the exposure of 12 percent of patients did not result in symptomatic infections.

Item Type: Article
Uncontrolled Keywords: BONE-MARROW-TRANSPLANTATION; INTRAVENOUS IMMUNE GLOBULIN; IMMUNOGLOBULIN THERAPY; VIRAL-DNA; INFECTION; TRANSMISSION; RECIPIENTS; APLASIA; VIRUS; PLASMA;
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Depositing User: Dr. Gernot Deinzer
Date Deposited: 26 Apr 2021 05:01
Last Modified: 26 Apr 2021 05:01
URI: https://pred.uni-regensburg.de/id/eprint/35504

Actions (login required)

View Item View Item